Deborah Dyer, RN, BSN, founded a clinical investigational site in Kentucky known as Central Kentucky Research Associates (CKRA) along with the late Jacqueline Smith, RN, BSN. CKRA was Kentucky’s first independent clinical research facilities and one of the few owned and operated by a women. Now part of a nationwide clinical research site operation called Alliance for Multispecialty Research (AMR), her Lexington, Kentucky office now participates in a critically important COVID-19 vaccine clinical involving Inovio Pharmaceutical’s INO-4800. For principal investigator Dr. Mark Adam, this represents an exciting opportunity to participate in a vaccine study with global imperative; for Lexington, Kentucky residents, this is an opportunity to step up and make a difference in the war against COVID-19.
Inovio Pharmaceuticals is based in Pennsylvania and as TrialSite News has suggested, could be the dark horse in the race to produce a COVID-19 vaccine candidate that is both safe and efficacious. A DNA-based vaccine that essentially tricks the body into thinking it is being invaded by SARS-CoV-2, has raised $9 million from the Coalition for Epidemic Preparedness Innovation...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).